Camurus AB
STO:CAMX
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
285.2
681
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
Camurus AB operates as a research based pharmaceutical company. [ Read More ]
The intrinsic value of one CAMX stock under the Base Case scenario is hidden SEK. Compared to the current market price of 662.5 SEK, Camurus AB is hidden .
Valuation Backtest
Camurus AB
Run backtest to discover the historical profit from buying and selling CAMX based on its intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Camurus AB
Current Assets | 3.2B |
Cash & Short-Term Investments | 2.6B |
Receivables | 398.2m |
Other Current Assets | 210m |
Non-Current Assets | 256.7m |
PP&E | 37.5m |
Intangibles | 22.8m |
Other Non-Current Assets | 196.5m |
Current Liabilities | 428.8m |
Accounts Payable | 70m |
Accrued Liabilities | 233.8m |
Other Current Liabilities | 125m |
Non-Current Liabilities | 74.9m |
Long-Term Debt | 10.6m |
Other Non-Current Liabilities | 64.4m |
Earnings Waterfall
Camurus AB
Revenue
|
1.6B
SEK
|
Cost of Revenue
|
-127.2m
SEK
|
Gross Profit
|
1.5B
SEK
|
Operating Expenses
|
-1.2B
SEK
|
Operating Income
|
236.8m
SEK
|
Other Expenses
|
-13.5m
SEK
|
Net Income
|
223.3m
SEK
|
Free Cash Flow Analysis
Camurus AB
SEK | |
Free Cash Flow | SEK |
CAMX Profitability Score
Profitability Due Diligence
Camurus AB's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Camurus AB's profitability score is hidden . The higher the profitability score, the more profitable the company is.
CAMX Solvency Score
Solvency Due Diligence
Camurus AB's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Camurus AB's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CAMX Price Targets Summary
Camurus AB
According to Wall Street analysts, the average 1-year price target for CAMX is 719.61 SEK with a low forecast of 545.4 SEK and a high forecast of 808.5 SEK.
Shareholder Yield
Current shareholder yield for CAMX is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
CAMX Price
Camurus AB
Average Annual Return | 46.03% |
Standard Deviation of Annual Returns | 61.46% |
Max Drawdown | -44% |
Market Capitalization | 39.9B SEK |
Shares Outstanding | 59 534 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Camurus AB operates as a research based pharmaceutical company. The company is headquartered in Lund, Skane and currently employs 148 full-time employees. The company went IPO on 2015-12-03. The firm has a diversified research portfolio, which includes five products in clinical trials, and a number of additional product candidates in the pre-clinical phase. The Company’s product pipeline represents a mix of in-house and partnered projects in different development phases. Camurus AB is the parent company of the Group, which comprises four legal entities, namely Camurus Inc, Cubosome Inc, Camurus Development AB and Bioimplant Scandinavia AB.
Officers
The intrinsic value of one CAMX stock under the Base Case scenario is hidden SEK.
Compared to the current market price of 662.5 SEK, Camurus AB is hidden .